open access
Sequential therapies in gastric gastrinoma
Affiliations- Department of Endocrinology and Neuroendocrine Tumours, Department of Pathophysiology and Endocrinology, Medical University of Silesia, Katowice, Poland
open access
Abstract
Not required for Clinical Vignette.
Abstract
Not required for Clinical Vignette.
Keywords
gNEN; gastrinoma; somatostatin analogues; PRRT
About this articleTitle
Sequential therapies in gastric gastrinoma
Journal
Issue
Article type
Clinical vignette
Pages
171-172
Published online
2022-02-14
Page views
5337
Article views/downloads
395
DOI
Pubmed
Bibliographic record
Endokrynol Pol 2022;73(1):171-172.
Keywords
gNEN
gastrinoma
somatostatin analogues
PRRT
Authors
Violetta Rosiek
References (5)- Okamoto T, Yoshimoto T, Ohike N, et al. Spontaneous regression of gastric gastrinoma after resection of metastases to the lesser omentum: A case report and review of literature. World J Gastroenterol. 2021; 27(1): 129–142.
- Rossi RE, Elvevi A, Citterio D, et al. Gastrinoma and Zollinger Ellison syndrome: A roadmap for the management between new and old therapies. World J Gastroenterol. 2021; 27(35): 5890–5907.
- Cingam SR, Botejue M, Hoilat GJ. Gastrinoma. StatPearls, Treasure Island 2021.
- Lipiński M, Rydzewska G, Foltyn W, et al. Nowotwory neuroendokrynne żołądka i dwunastnicy z uwzględnieniem gastrinoma (zasady postępowania rekomendowane przez Polską Sieć Guzów Neuroendokrynnych). Endokrynol Pol. 2017; 68(2): 138–153.
- Pavel M, Öberg K, Falconi M, et al. ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020; 31(7): 844–860.
